Use of bioresorbable membranes to reduce abdominal and perihepatic adhesions in 2-stage hepatectomy of liver metastases from colorectal cancer: Results of a prospective, randomized controlled phase II trial

Annals of Surgery

Volumn 258, Issue 1, 2013, Pages 30-36

  Dupré, Aurélien ^a   Lefranc, Anne ^a   Buc, Emmanuel ^b   Delpero, Jean Robert ^c   Quenet, François ^d   Passot, Guillaume ^e   Evrard, Serge ^f   Rivoire, Michel ^a  

^a CENTRE LÉON BÉRARD   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c INSTITUT PAOLI CALMETTES   (France)

^d CENTRE VAL D AURELLE   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f INSTITUT BERGONIÉ   (France)

Author keywords

2 Stage hepatectomy; Adhesion prevention; Clinical trial; Colorectal cancer; Hepatectomy; Liver metastases; Seprafilm; Sodium hyaluronate carboxymethyl cellulose

Indexed keywords

BEVACIZUMAB; CARBOXYMETHYLCELLULOSE; CETUXIMAB; FLUOROURACIL; HYALURONIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; LIVER METASTASIS; LIVER RESECTION; LONG TERM SURVIVAL; MALE; METASTATIC COLORECTAL CANCER; MULTIMODALITY CANCER THERAPY; PERITONEUM ADHESION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT;

ABSORBABLE IMPLANTS; ADULT; AGED; CARBOXYMETHYLCELLULOSE SODIUM; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; HYALURONIC ACID; LIVER NEOPLASMS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PROSPECTIVE STUDIES; REOPERATION; SURVIVAL RATE; TISSUE ADHESIONS; TREATMENT OUTCOME;

EID: 84879110863     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182854949     Document Type: Article

References (22)

1. Ellis H. The clinical significance of adhesions: focus on intestinal obstruction. Eur J Surg Suppl. 1997;5-9.
2. Becker JM, Dayton MT, Fazio VW, et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg. 1996;183:297-306.
3. Kusunoki M, Ikeuchi H, Yanagi H, et al. Bioresorbable hyaluronatecarboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial. Surg Today. 2005;35:940-945.
4. Kumar S, Wong PF, Leaper DJ. Intra-peritoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction after non-gynaecological abdominal surgery. Cochrane Database Syst Rev. 2009; CD005080.
5. Hayashi S, Takayama T, Masuda H, et al. Bioresorbable membrane to reduce postoperative small bowel obstruction in patients with gastric cancer: a randomized clinical trial. Ann Surg. 2008;247:766-770.
6. Tang CL, Jayne DG, Seow-Choen F, et al. A randomized controlled trial of 0.5% ferric hyaluronate gel (Intergel) in the prevention of adhesions following abdominal surgery. Ann Surg. 2006;243:449-455.
7. Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg. 2000;231:487-499.
8. De Haas RJ, Wicherts DA, Andreani P, et al. Impact of expanding criteria for resectability of colorectal metastases on short-and long-term outcomes after hepatic resection. Ann Surg. 2011;253:1069-1079.
9. Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224:509-520.
10. Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777-785.
11. Jaeck D, Oussoultzoglou E, Rosso E, et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg. 2004;240:1037-1049.
12. Wicherts DA, Miller R, De Haas RJ, et al. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg. 2008;248:994-1005.
13. Brouquet A, Abdalla EK, Kopetz S, et al. High survival rate after two-stage resection of advanced colorectal livermetastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011;29:1083-1090.
14. Beck DE, Cohen Z, Fleshman JW, et al. A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon Rectum. 2003;46:1310-1319.
15. Herson J, Carter SK. Calibrated phase II clinical trials in oncology. Stat Med. 1986;5:441-447.
16. Rubinstein L, Crowley J, Ivy P, et al. Randomized phase II designs. Clin Cancer Res. 2009;15:1883-1890.
17. Zuhlke HV, Lorenz EM, Straub EM, et al. Pathophysiology and classification of adhesions. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1990;1009-1016.
18. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
19. Jones RP, Jackson R, Dunne DF, et al. Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases. Br J Surg. 2012;99:477-486.
20. Vrijland WW, Tseng LN, Eijkman HJ, et al. Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial. Ann Surg. 2002;235:193-199.
21. Capussotti L, Ferrero A, Vigano L, et al. Major liver resections synchronous with colorectal surgery. Ann Surg Oncol. 2007;14:195-201.
22. Van Den Broek MA, Van Dam RM, Malago M, et al. Feasibility of randomized controlled trials in liver surgery using surgery-related mortality or morbidity as endpoint. Br J Surg. 2009;96:1005-1014.